Telomir Pharmaceuticals, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -1,718 | -989 | -2,062 | -1,099 |
EBIT | -1,718 | -989 | -2,062 | -1,102 |
Net Income | -1,721 | -990 | -2,061 | -1,102 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,012 | -1,773 | -1,201 | -927 |
Cash | 5,170 | 5,560 | 7,286 | 7,329 |
Basic Shares | 34,380 | 34,380 | 34,380 | 31,039 |
Annual Financials
| Values in thousands | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -3,942 | |||
EBITDA | -10,413 | -7,855 | -11,428 | -854 |
EBIT | -10,413 | -12,194 | -3,942 | -1,708 |
Net Income | -10,413 | -16,532 | -13,071 | -854 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,688 | -5,070 | -3,859 | -468 |
Cash | 7,286 | 1,266 | 1 | 1 |
Basic Shares | 31,653 | 29,539 | 29,609 | 29,609 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.79 |
2026-03-31 | -$0.02 |
2025-12-31 | -$0.06 |
2025-09-30 | -$0.03 |